A study of efficacy and safety of cryogenic device for home use (EndWarts FREEZE) in the treatment of palmo/plantar warts

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210204002

Enrollment

Registered

2021-02-04

Start date

2020-06-16

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

palmo/plantar warts Warts, Cryotherapy, Home treatment, Nitrous oxide

Interventions

Cryogenic device for home use

Experimental Device

Endwarts Freeze

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, 18-70 years of age, with palmo/plantar wart less than 0.5 cm 2. Subjects must willingly give informed consent and can comply with a study protocol.

Exclusion criteria

Exclusion criteria: 1. Subjects who have received other wart treatment within 2 months prior to baseline. 2. Subjects with the presence of wound, infection or other skin conditions at the treatment site. 3. A pregnant woman or nursing or unable to use non-hormonal birth control. 4. Subjects with diabetes mellitus, cryoglobelinemia or any circulatory disease. 5. Subject with cold allergy.

Design outcomes

Primary

Measure	Time frame
wart size 1, 2 months after treatment vernier caliper	—

Secondary

Measure	Time frame
volume 1, 2 months after treatment antera,Patient satisfaction assessment 1, 2 months after treatment Satisfaction score,side effects 1, 2 months after treatment questionaire	—

Countries

Thailand

Contacts

Public ContactMarisa Pongprutthipan

Chulalongkorn University

dr_marisa@yahoo.com0853620400

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026